| Cancer Information Highlights |
| From the National Cancer Institute |
| Updating you about cancer causes, prevention, screening, treatment, coping, and more |
| |
| New from NCI |
| Targeted Therapy Approved to Treat Lung and Pancreatic Cancers with Rare Genetic Change |
 |
|
The Food and Drug Administration has approved zenocutuzumab (Bizengri) to treat people with pancreatic or non-small cell lung cancer whose tumors have a rare genetic change called an NRG1 fusion. The approval is based on a clinical trial in which the drug shrank tumors in a third of patients.
Read More
|
| Experimental Treatment Uses Engineered Fat Cells to “Starve” Tumors |
 |
|
Researchers have developed a cancer treatment that uses fat cells engineered to consume nutrients like glucose. When implanted in mice, the engineered cells appeared to outcompete tumors for nutrients, shrinking tumors.
Read More
|
Combination Immunotherapy Shrank a Variety of Metastatic Solid Cancers
A new form of tumor-infiltrating lymphocyte (TIL) therapy combined with pembrolizumab (Keytruda) caused tumors to shrink in nearly a quarter of patients with metastatic gastrointestinal cancers. This form of TIL therapy involves selecting immune cells (TILs) from a person’s tumor that actively recognize and attack specific proteins on their tumor cells, multiplying the TILs in a lab, and infusing them back into the patient.
Read More
|
|
Childhood Nasopharyngeal Cancer
Nasopharyngeal cancer is cancer that forms in the upper part of the throat, behind the nose. In children, it is linked to Epstein-Barr virus. Visit our updated page to learn more about this cancer in children and how it is treated.
Read More
|
|
| |
|
|
|
|
|
|
